← Back to headlines
Novo Nordisk Expands Wegovy Subscriptions to Hims, LifeMD, and Other Platforms
Novo Nordisk has introduced multi-month subscription plans for its obesity drug, Wegovy, offering lower monthly pricing and expanding sales channels to include platforms like Hims and LifeMD to compete with rivals.
31 Mar, 11:39 — 31 Mar, 14:28
The Story
Analyzing sources…
Source Diversity
Source Diversity
High (56/100)4 sources30/33
Spectrum spread— 3/5 buckets covered17/33
Far L
Left1
Left (1)
cnbc
Center2
Center (2)
Reutersforbes
Right1
Right (1)
seeking-alpha
Far R
Geographic diversity— 2 regions9/34
US3Intl1
Sources
Showing 4 of 4 sources
ReutersVery High8h ago
Novo Nordisk to launch discounted Wegovy subscriptions for self-pay patients in US - Reuters
Novo Nordisk to launch discounted Wegovy subscriptions for self-pay patients in US Reuters
Read full article →cnbcMostly Factual11h ago
Novo Nordisk launches multi-month subscriptions for Wegovy obesity drugs as it tries to catch up with Eli Lilly
Longer subscriptions offer lower monthly pricing, with people expected to save up to $1,200 a year on the injection and as much as $600 a year on the pill.
Read full article →forbes11h ago
Wegovy Subscription Launched—Here’s How Much It Could Save Users A Year - Forbes
Wegovy Subscription Launched—Here’s How Much It Could Save Users A Year Forbes
Read full article →seeking-alphaMixed11h ago
Novo to sell Wegovy subscriptions on Hims, LifeMD, and others
Read full article →Coverage Timeline
First report: cnbc · 31 Mar, 11:39|Full coverage: 4 · 3h|Window: 3h
Left-leaningCenterRight-leaning
